Browsing Tag
Morgans
2 posts
Why Cochlear (ASX: COH) is bouncing despite a 40.5% drop since the April FY26 downgrade
Cochlear bounced 2.31% today, but the stock sits 40% below pre-downgrade levels. The August FY26 result is where management's recovery thesis either holds or breaks.
GemLife targets A$1.5B valuation in ASX IPO: Can it outperform Lifestyle Communities and Ingenia?
GemLife eyes a A$1.1B ASX listing with a A$700M IPO—explore how retirement housing demand and land lease models fuel investor interest.